Cargando…
Rapid diagnostic tests for determining dengue serostatus: a systematic review and key informant interviews
OBJECTIVES: Vaccination for dengue with the live attenuated tetravalent CYD-TDV vaccine (Dengvaxia®) is only recommended in individuals who have had prior dengue virus (DENV) infection. Rapid diagnostic tests (RDT) for past DENV infection would offer a convenient method for pre-vaccination screening...
Autores principales: | Luo, R., Fongwen, N., Kelly-Cirino, C., Harris, E., Wilder-Smith, A., Peeling, R.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543064/ https://www.ncbi.nlm.nih.gov/pubmed/30664935 http://dx.doi.org/10.1016/j.cmi.2019.01.002 |
Ejemplares similares
-
Field evaluation of rapid diagnostic tests to determine dengue serostatus in Timor-Leste
por: Arkell, Paul, et al.
Publicado: (2022) -
Performance Evaluation of a Dengue IgG Rapid Diagnostic Test Designed to Determine Dengue Serostatus as Part of Prevaccination Screening
por: Liberal, Vasco, et al.
Publicado: (2022) -
Serostatus testing and dengue vaccine cost–benefit thresholds
por: Pearson, Carl A. B., et al.
Publicado: (2019) -
Target product profile for a dengue pre-vaccination screening test
por: Fongwen, Noah, et al.
Publicado: (2021) -
Risk of dengue virus infection according to serostatus in individuals from dengue endemic areas of Mexico
por: Amaya-Larios, I. Y., et al.
Publicado: (2020)